321 related articles for article (PubMed ID: 33559399)
1. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
3. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
[TBL] [Abstract][Full Text] [Related]
8. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
Carter M; Solsrud K; Yeddula S; Fitzmaurice MG; Singh A; Nagai S; Jafri SM
Transplant Proc; 2022 Sep; 54(7):1737-1741. PubMed ID: 35907694
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
11. Infection with hepatitis E virus in kidney transplant recipients in southeastern France.
Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P
J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466
[TBL] [Abstract][Full Text] [Related]
12. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
13. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
Owada Y; Oshiro Y; Inagaki Y; Harada H; Fujiyama N; Kawagishi N; Yagisawa T; Usui J; Akutsu N; Itabashi Y; Saito K; Watarai Y; Ichimaru N; Imamura R; Kyakuno M; Ide K; Shibuya Y; Okabe Y; Ono M; Sasaki K; Shiose A; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Yuzawa K; Okamoto H; Ohkohchi N
Transplantation; 2020 Feb; 104(2):437-444. PubMed ID: 31205267
[TBL] [Abstract][Full Text] [Related]
14. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.
Nijskens CM; Pas SD; Cornelissen J; Caliskan K; Hoek RA; Hesselink DA; van der Eijk AA; de Man RA
J Clin Virol; 2016 Jan; 74():82-7. PubMed ID: 26687439
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients.
Koning L; Pas SD; de Man RA; Balk AH; de Knegt RJ; ten Kate FJ; Osterhaus AD; van der Eijk AA
J Heart Lung Transplant; 2013 Jan; 32(1):78-85. PubMed ID: 23260707
[TBL] [Abstract][Full Text] [Related]
18. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.
Del Bello A; Abravanel F; Alric L; Lavayssiere L; Lhomme S; Bellière J; Izopet J; Kamar N
Transpl Infect Dis; 2019 Aug; 21(4):e13093. PubMed ID: 30972874
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
[TBL] [Abstract][Full Text] [Related]
20. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]